Ironwood Pharmaceuticals Inc SEC filings IRWD

Ironwood Pharmaceuticals Inc has 1,003 filings in SEC EDGAR's recent list, going back to Nov 4, 2014. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Ironwood Pharmaceuticals Inc SEC filings
Form Description Filed Period
S-8 Employee stock plan registration Nov 5, 2026 —
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 5, 2026 Nov 5, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 28, 2026 —
8-K Current report
Officer or director change
Oct 16, 2026 Oct 12, 2026
144 Notice of proposed sale Sep 23, 2026 —
4 Insider transaction Sep 17, 2026 Sep 15, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Aug 7, 2026 —
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 28, 2026 —
4 Insider transaction Jul 22, 2026 Jul 20, 2026
3 Initial insider ownership Jul 22, 2026 Jul 20, 2026
4 Insider transaction Jul 9, 2026 Jul 7, 2026
144 Notice of proposed sale Jul 7, 2026 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 18, 2026 Jun 16, 2026
4 Insider transaction Jun 17, 2026 Jun 16, 2026
4 Insider transaction Jun 17, 2026 Jun 16, 2026
4 Insider transaction Jun 17, 2026 Jun 16, 2026
4 Insider transaction Jun 17, 2026 Jun 16, 2026
4 Insider transaction Jun 17, 2026 Jun 15, 2026
4 Insider transaction Jun 17, 2026 Jun 16, 2026
4 Insider transaction Jun 17, 2026 Jun 16, 2026
144 Notice of proposed sale Jun 16, 2026 —
8-K Current report
Other events
Jun 15, 2026 Jun 15, 2026
8-K/A Amended current report
Officer or director change
May 21, 2026 May 8, 2026
4 Insider transaction May 21, 2026 May 19, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 14, 2026 —
8-K Current report
Officer or director change
May 13, 2026 May 8, 2026
10-Q Quarterly report May 7, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 7, 2026 May 7, 2026
ARS Annual report to shareholders Apr 28, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 28, 2026 —
DEF 14A Proxy statement Apr 28, 2026 Jun 16, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 27, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Mar 19, 2026 —
4 Insider transaction Mar 17, 2026 Mar 13, 2026
4 Insider transaction Mar 12, 2026 Mar 10, 2026
4 Insider transaction Mar 12, 2026 Mar 10, 2026
4 Insider transaction Mar 12, 2026 Mar 10, 2026
4 Insider transaction Mar 12, 2026 Mar 10, 2026
4 Insider transaction Mar 12, 2026 Mar 10, 2026
4 Insider transaction Mar 12, 2026 Mar 10, 2026
8-K Current report
Other events
Mar 11, 2026 Mar 10, 2026
10-K Annual report Feb 26, 2026 Dec 31, 2025
4 Insider transaction Feb 25, 2026 Feb 23, 2026
4 Insider transaction Feb 25, 2026 Feb 23, 2026
4 Insider transaction Feb 25, 2026 Feb 23, 2026
4 Insider transaction Feb 25, 2026 Feb 23, 2026
4 Insider transaction Feb 25, 2026 Feb 23, 2026
4 Insider transaction Feb 25, 2026 Feb 23, 2026
8-K Current report
Results of operations
Feb 25, 2026 Feb 25, 2026
144 Notice of proposed sale Feb 20, 2026 —
144 Notice of proposed sale Feb 20, 2026 —
144 Notice of proposed sale Feb 20, 2026 —
144 Notice of proposed sale Feb 20, 2026 —
144 Notice of proposed sale Feb 20, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
4 Insider transaction Jan 7, 2026 Jan 5, 2026
144 Notice of proposed sale Jan 5, 2026 —
8-K Current report
Results of operations
Jan 2, 2026 Jan 2, 2026
8-K Current report
Material agreement, Other events
Dec 23, 2025 Dec 18, 2025
4 Insider transaction Dec 17, 2025 Dec 15, 2025
8-K Current report
Other events
Nov 26, 2025 Nov 25, 2025
4 Insider transaction Nov 19, 2025 Nov 17, 2025
144 Notice of proposed sale Nov 14, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 12, 2025 —
8-K Current report
Results of operations
Nov 10, 2025 Nov 10, 2025
10-Q Quarterly report Nov 10, 2025 Sep 30, 2025
8-K Current report
Officer or director change
Oct 10, 2025 Oct 7, 2025
4 Insider transaction Sep 17, 2025 Sep 15, 2025
8-K Current report
Other events
Sep 3, 2025 Aug 29, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 15, 2025 —
4 Insider transaction Aug 13, 2025 Aug 11, 2025
4 Insider transaction Aug 13, 2025 Aug 11, 2025
4 Insider transaction Aug 13, 2025 Aug 11, 2025
4 Insider transaction Aug 13, 2025 Aug 11, 2025
SCHEDULE 13G Ownership over 5% (passive) Aug 12, 2025 —
10-Q Quarterly report Aug 11, 2025 Jun 30, 2025
144 Notice of proposed sale Aug 8, 2025 —
144 Notice of proposed sale Aug 8, 2025 —
144 Notice of proposed sale Aug 8, 2025 —
8-K Current report
Results of operations
Aug 7, 2025 Aug 7, 2025
8-K Current report
Auditor change
Jul 10, 2025 Jul 3, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 7, 2025 —
4 Insider transaction Jun 17, 2025 Jun 13, 2025
4 Insider transaction Jun 12, 2025 Jun 10, 2025
4 Insider transaction Jun 12, 2025 Jun 10, 2025
4 Insider transaction Jun 12, 2025 Jun 10, 2025
4 Insider transaction Jun 12, 2025 Jun 10, 2025
4 Insider transaction Jun 12, 2025 Jun 10, 2025
4 Insider transaction Jun 12, 2025 Jun 10, 2025
4 Insider transaction Jun 12, 2025 Jun 10, 2025
8-K Current report
Shareholder vote results
Jun 12, 2025 Jun 10, 2025
4 Insider transaction Jun 12, 2025 Jun 10, 2025
8-K Current report
Listing notice
Jun 3, 2025 May 28, 2025
4 Insider transaction May 20, 2025 May 16, 2025
4 Insider transaction May 20, 2025 May 16, 2025
144 Notice of proposed sale May 16, 2025 —
144 Notice of proposed sale May 16, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
SCHEDULE 13G Ownership over 5% (passive) May 13, 2025 —
10-Q Quarterly report May 12, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 7, 2025 May 7, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 2, 2025 —
SCHEDULE 13G Ownership over 5% (passive) May 2, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 30, 2025 —
ARS Annual report to shareholders Apr 28, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 28, 2025 —
DEF 14A Proxy statement Apr 28, 2025 Jun 10, 2025
8-K Current report
Results of operations
Apr 25, 2025 Apr 25, 2025
8-K Current report
Other events
Apr 14, 2025 Apr 14, 2025
4 Insider transaction Apr 4, 2025 Apr 2, 2025
10-K Annual report Mar 31, 2025 Dec 31, 2024
8-K Current report
Listing notice, Regulation FD disclosure
Mar 27, 2025 Mar 21, 2025
3 Initial insider ownership Mar 21, 2025 Mar 11, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 7, 2025 —
NT 10-K Filing Mar 3, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 27, 2025 Feb 27, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
4 Insider transaction Feb 12, 2025 Feb 10, 2025
4 Insider transaction Feb 12, 2025 Feb 10, 2025
4 Insider transaction Feb 12, 2025 Feb 10, 2025
4 Insider transaction Feb 12, 2025 Feb 10, 2025
4 Insider transaction Feb 12, 2025 Feb 10, 2025
144 Notice of proposed sale Feb 7, 2025 —
144 Notice of proposed sale Feb 7, 2025 —
144 Notice of proposed sale Feb 7, 2025 —
144 Notice of proposed sale Feb 7, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Feb 5, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 31, 2025 —
4 Insider transaction Jan 29, 2025 Jan 27, 2025
4 Insider transaction Jan 29, 2025 Jan 27, 2025
3 Initial insider ownership Jan 29, 2025 Jan 27, 2025
8-K Current report
Exit or restructuring costs, Officer or director change
Jan 29, 2025 Jan 17, 2025
4 Insider transaction Jan 22, 2025 Jan 17, 2025
4 Insider transaction Jan 22, 2025 Jan 17, 2025
4 Insider transaction Jan 22, 2025 Jan 17, 2025
144 Notice of proposed sale Dec 27, 2024 —
4 Insider transaction Dec 18, 2024 Dec 16, 2024
8-K Current report
Officer or director change
Dec 5, 2024 Dec 2, 2024
4 Insider transaction Nov 20, 2024 Nov 18, 2024
4 Insider transaction Nov 20, 2024 Nov 18, 2024
144 Notice of proposed sale Nov 15, 2024 —
144 Notice of proposed sale Nov 15, 2024 —
SC 13G Ownership over 5% (passive) Nov 14, 2024 —
SCHEDULE 13G Ownership over 5% (passive) Nov 13, 2024 —
8-K Current report
Officer or director change
Nov 12, 2024 Nov 6, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 8, 2024 —
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 7, 2024 Nov 7, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 4, 2024 —
SC 13G/A Amended ownership over 5% (passive) Oct 23, 2024 —
SC 13G/A Amended ownership over 5% (passive) Oct 16, 2024 —
8-K Current report
Material agreement, New debt, Other events
Sep 30, 2024 Sep 27, 2024
4 Insider transaction Sep 18, 2024 Sep 16, 2024
4 Insider transaction Aug 14, 2024 Aug 12, 2024
4 Insider transaction Aug 14, 2024 Aug 12, 2024
144 Notice of proposed sale Aug 9, 2024 —
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 8, 2024 Aug 8, 2024
4 Insider transaction Jun 21, 2024 Jun 18, 2024
4 Insider transaction Jun 21, 2024 Jun 18, 2024
4 Insider transaction Jun 21, 2024 Jun 18, 2024
4 Insider transaction Jun 21, 2024 Jun 18, 2024
4 Insider transaction Jun 21, 2024 Jun 18, 2024
4 Insider transaction Jun 21, 2024 Jun 18, 2024
4 Insider transaction Jun 21, 2024 Jun 18, 2024
4 Insider transaction Jun 21, 2024 Jun 18, 2024
8-K Current report
Shareholder vote results
Jun 21, 2024 Jun 21, 2024
8-K Current report
Officer or director change, Other events
Jun 20, 2024 Jun 20, 2024
4 Insider transaction Jun 18, 2024 Jun 15, 2024
4 Insider transaction Jun 12, 2024 Jun 10, 2024
4 Insider transaction Jun 10, 2024 Jun 6, 2024
144 Notice of proposed sale Jun 10, 2024 —
144 Notice of proposed sale Jun 7, 2024 —
144 Notice of proposed sale Jun 6, 2024 —
4 Insider transaction May 22, 2024 May 20, 2024
4 Insider transaction May 22, 2024 May 20, 2024
4 Insider transaction May 22, 2024 May 20, 2024
4 Insider transaction May 22, 2024 May 20, 2024
4 Insider transaction May 20, 2024 May 16, 2024
144 Notice of proposed sale May 17, 2024 —
144 Notice of proposed sale May 17, 2024 —
144 Notice of proposed sale May 17, 2024 —
144 Notice of proposed sale May 17, 2024 —
10-Q Quarterly report May 9, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 9, 2024 May 9, 2024
ARS Annual report to shareholders Apr 25, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 25, 2024 —
DEF 14A Proxy statement Apr 25, 2024 Jun 18, 2024
4 Insider transaction Mar 19, 2024 Mar 15, 2024
4 Insider transaction Mar 12, 2024 Mar 8, 2024
4 Insider transaction Mar 12, 2024 Mar 8, 2024
4 Insider transaction Mar 12, 2024 Mar 8, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
IRWD (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Boston, MA
SEC filer status
Accelerated filer, Smaller reporting company
SEC CIK
1446847

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.